These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 17378442)
1. Oral and intravenous administration of nimesulide in the horse: rational dosage regimen from pharmacokinetic and pharmacodynamic data. Villa R; Cagnardi P; Belloli C; Zonca A; Zizzadoro C; Ferro E; Carli S Equine Vet J; 2007 Mar; 39(2):136-42. PubMed ID: 17378442 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog. Toutain PL; Cester CC; Haak T; Metge S J Vet Pharmacol Ther; 2001 Feb; 24(1):35-42. PubMed ID: 11348485 [TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog. Toutain PL; Cester CC; Haak T; Laroute V J Vet Pharmacol Ther; 2001 Feb; 24(1):43-55. PubMed ID: 11348486 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioavailability of nimesulide in goats. Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902 [TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic comparison of three pharmaceutical formulations of nimesulide in healthy volunteers. Jovanović D; Kilibarda V; Todorović V; Potrebić O Vojnosanit Pregl; 2005 Dec; 62(12):887-93. PubMed ID: 16375216 [TBL] [Abstract][Full Text] [Related]
6. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse. Rees WA; Harkins JD; Woods WE; Blouin RA; Lu M; Fenger C; Holland RE; Chambers TM; Tobin T Equine Vet J; 1997 Mar; 29(2):104-10. PubMed ID: 9104558 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Pohjolainen T; Jekunen A; Autio L; Vuorela H Spine (Phila Pa 1976); 2000 Jun; 25(12):1579-85. PubMed ID: 10851109 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of nimesulide. Bernareggi A Clin Pharmacokinet; 1998 Oct; 35(4):247-74. PubMed ID: 9812177 [TBL] [Abstract][Full Text] [Related]
9. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology. Lees P; Giraudel J; Landoni MF; Toutain PL J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of etodolac in the horse following oral and intravenous administration. Davis JL; Papich MG; Morton AJ; Gayle J; Blikslager AT; Campbell NB J Vet Pharmacol Ther; 2007 Feb; 30(1):43-8. PubMed ID: 17217400 [TBL] [Abstract][Full Text] [Related]
11. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Suleyman H; Cadirci E; Albayrak A; Halici Z Curr Med Chem; 2008; 15(3):278-83. PubMed ID: 18333314 [TBL] [Abstract][Full Text] [Related]
12. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs. Steiner AA; Li S; Llanos-Q J; Blatteis CM Neuroimmunomodulation; 2001; 9(5):263-75. PubMed ID: 11964521 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and in vitro cyclooxygenase selectivity of deracoxib in horses. Davis JL; Marshall JF; Papich MG; Blikslager AT; Campbell NB J Vet Pharmacol Ther; 2011 Feb; 34(1):12-6. PubMed ID: 21219338 [TBL] [Abstract][Full Text] [Related]
14. Distribution of oral nimesulide in female genital tissues. Pulkkinen MO; Vuento M; Macciocchi A; Monti T Biopharm Drug Dispos; 1991 Mar; 12(2):113-7. PubMed ID: 2031992 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction. Cornelisse CJ; Robinson NE; Berney CE; Kobe CA; Boruta DT; Derksen FJ Equine Vet J; 2004 Jul; 36(5):426-30. PubMed ID: 15253084 [TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory activity and pharmacokinetic profile of a new parenteral formulation of nimesulide. Gupta SK; Bhardwaj RK; Tyagi P; Sengupta S; Velpandian T Pharmacol Res; 1999 Feb; 39(2):137-41. PubMed ID: 10072704 [TBL] [Abstract][Full Text] [Related]
17. Relationship of nimesulide safety to its pharmacokinetics: assessment of adverse reactions. Rainsford KD Rheumatology (Oxford); 1999 May; 38 Suppl 1():4-10. PubMed ID: 10369399 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of danofloxacin in horses after intravenous, intramuscular and intragastric administration. Fernández-Varón E; Ayala I; Marín P; Carrión A; Martos N; Escudero E; Cárceles CM Equine Vet J; 2006 Jul; 38(4):342-6. PubMed ID: 16866202 [TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib. Giraudel JM; Toutain PL; King JN; Lees P J Vet Pharmacol Ther; 2009 Feb; 32(1):31-40. PubMed ID: 19161453 [TBL] [Abstract][Full Text] [Related]
20. Quantification of nimesulide in human plasma by high-performance liquid chromatography with ultraviolet detector (HPLC-UV): application to pharmacokinetic studies in 28 healthy Korean subjects. Kim MS; Park YS; Kim SH; Kim SY; Lee MH; Kim YH; Kim DW; Yang SC; Kang JS J Chromatogr Sci; 2012 May; 50(5):396-400. PubMed ID: 22451531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]